FDA product codes
The device classification tree, in product code order.
FDA classifies every device type under a three-letter product code, and that code is what ties a clearance to a recall to a registered listing. Each page here carries the FDA definition, the regulation it sits under, clearance volume by year, and the companies that list the code with FDA.
Data as of , the FDA export date. FDA product classification database
Review panels
6,880 codes| Review panel | Panel code | Product codes |
|---|---|---|
| Anesthesiology | AN | 262 |
| Cardiovascular | CV | 437 |
| Clinical Chemistry | CH | 527 |
| Clinical Toxicology | TX | 338 |
| Dental | DE | 352 |
| Ear, Nose, Throat | EN | 269 |
| Gastroenterology, Urology | GU | 614 |
| General Hospital | HO | 394 |
| General, Plastic Surgery | SU | 562 |
| Hematology | HE | 281 |
| Immunology | IM | 278 |
| Medical Genetics | MG | 7 |
| Microbiology | MI | 554 |
| Neurology | NE | 291 |
| Obstetrics/Gynecology | OB | 269 |
| Ophthalmic | OP | 345 |
| Orthopedic | OR | 349 |
| Pathology | PA | 325 |
| Physical Medicine | PM | 210 |
| Radiology | RA | 216 |
| Code | Device name | Class | Regulation | Clearances | Recalls |
|---|---|---|---|---|---|
| GKZ | Counter, Differential Cell | Class II | 21 CFR 864.5220 | 381 | 244 |
| GLE | Mixer, Blood Tube | Class I | 21 CFR 862.2050 | 5 | 0 |
| GLG | Platelet Counting, Manual | Class I | 21 CFR 864.6160 | 3 | 0 |
| GLK | Control, Hematocrit | Class II | 21 CFR 864.8625 | 7 | 0 |
| GLQ | Mixture, Control, White-Cell And Red-Cell Indices | Class II | 21 CFR 864.8625 | 10 | 0 |
| GLY | Oximeter To Measure Hemoglobin | Class II | 21 CFR 864.7500 | 5 | 0 |
| GLZ | Antigens, If, Toxoplasma Gondii | Class II | 21 CFR 866.3780 | 18 | 0 |
| GMA | Antisera, Fluorescent, Sporothrix Schenekii | Class I | 21 CFR 866.3680 | 1 | 0 |
| GMB | Light, Wood'S, Fluorescence | Class I | 21 CFR 866.2600 | 0 | 0 |
| GMD | Antisera, Latex Agglutination, Cryptococcus Neoformans | Class II | 21 CFR 866.3165 | 10 | 3 |
| GME | Antisera, Fluorescent, Cryptococcus Neoformans | Class II | 21 CFR 866.3165 | 0 | 0 |
| GMG | Antigen, Latex Agglutination, Coccidioides Immitis | Class II | 21 CFR 866.3135 | 5 | 0 |
| GMH | Antiserum, Positive Control, Coccidioides Immitis | Class II | 21 CFR 866.3135 | 5 | 0 |
| GMI | Antigen, Cf And / Or Id, Coccidioides Immitis | Class II | 21 CFR 866.3135 | 11 | 1 |
| GMJ | Antigens, Histoplasma Capsulatum, All | Class II | 21 CFR 866.3320 | 12 | 2 |
| GMK | Antiserum, Positive Control, Histoplasma Capsulatum | Class II | 21 CFR 866.3320 | 9 | 0 |
| GML | Antisera, Fluorescent, Histoplasma Capsulatum | Class II | 21 CFR 866.3320 | 0 | 0 |
| GMM | Antigens, Iha, Toxoplasma Gondii | Class II | 21 CFR 866.3780 | 8 | 0 |
| GMN | Antigens, Cf, Toxoplasma Gondii | Class II | 21 CFR 866.3780 | 3 | 0 |
| GMO | Antigen, Latex Agglutination, Entamoeba Histolytica & Rel. Spp. | Class II | 21 CFR 866.3220 | 0 | 0 |
| GMP | Antisera, Control For Nontreponemal Tests | Class II | 21 CFR 866.3820 | 9 | 0 |
| GMQ | Antigens, Nontreponemal, All | Class II | 21 CFR 866.3820 | 32 | 0 |
| GMR | Sera, Reactive And Non-Specific Control, Fta-Abs Test | Class II | 21 CFR 866.3830 | 0 | 0 |
| GMS | Anti-Human Globulin, Fta-Abs Test | Class II | 21 CFR 866.3830 | 3 | 0 |
| GMT | Antigens, Ha, Treponema Pallidum | Class II | 21 CFR 866.3830 | 9 | 0 |
| GMW | Test, Sorbent, Fta-Abs | Class II | 21 CFR 866.3830 | 0 | 2 |
| GMX | Antisera, Fluorescent Antibody For Fta-Abs Test | Class II | 21 CFR 866.3830 | 0 | 0 |
| GMY | Antisera, Fluorescent, All Types, Escherichia Coli | Class I | 21 CFR 866.3255 | 2 | 0 |
| GMZ | Antigens, All Types, Escherichia Coli | Class I | 21 CFR 866.3255 | 14 | 2 |
| GNA | Antisera, All Types, Escherichia Coli | Class I | 21 CFR 866.3255 | 12 | 1 |
| GNB | Antisera, All Types, Shigella Spp. | Class II | 21 CFR 866.3660 | 41 | 3 |
| GNC | Antigens, Febrile, Slide And Tube, All Groups, Salmonella Spp. | Class II | 21 CFR 866.3550 | 60 | 5 |
| GND | Antigen, Iha, T. Cruzi | Class I | 21 CFR 866.3870 | 0 | 0 |
| GNE | Antigen, Latex Agglutination, T. Cruzi | Class I | 21 CFR 866.3870 | 1 | 0 |
| GNF | Antigen, Cf, T. Cruzi | Class I | 21 CFR 866.3870 | 0 | 0 |
| GNG | Antigens, Cf (Including Cf Control), Coxsackievirus A 1-24, B 1-6 | Class I | 21 CFR 866.3145 | 2 | 0 |
| GNH | Antigen, Fluorescent Antibody Test, Schistosoma Mansoni | Class I | 21 CFR 866.3600 | 2 | 0 |
| GNI | Antisera, Neutralization, Echovirus 1-34 | Class I | 21 CFR 866.3205 | 0 | 0 |
| GNJ | Antigens, Ha, Echovirus 1-34 | Class I | 21 CFR 866.3205 | 1 | 0 |
| GNK | Antisera, Cf, Echovirus 1-34 | Class I | 21 CFR 866.3205 | 3 | 0 |
| GNL | Antigens, Cf (Including Cf Control), Echovirus 1-34 | Class I | 21 CFR 866.3205 | 2 | 0 |
| GNM | Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6 | Class I | 21 CFR 866.3145 | 9 | 0 |
| GNN | Antisera, Neutralization, Coxsackievirus A 1-24, B 1-6 | Class I | 21 CFR 866.3145 | 1 | 0 |
| GNO | Antisera, Cf, Coxsackievirus A 1-24, B 1-6 | Class I | 21 CFR 866.3145 | 1 | 0 |
| GNP | Antiserum, Cf, Epstein-Barr Virus | Class I | 21 CFR 866.3235 | 20 | 2 |
| GNQ | Antigen, Cf (Including Cf Control), Epstein-Barr Virus | Class I | 21 CFR 866.3235 | 0 | 0 |
| GNR | Antisera, Neutralization, Influenza Virus A, B, C | Class I | 21 CFR 866.3330 | 1 | 0 |
| GNS | Antisera, Hai, Influenza Virus A, B, C | Class I | 21 CFR 866.3330 | 9 | 0 |
| GNT | Antigens, Ha (Including Ha Control), Influenza Virus A, B, C | Class I | 21 CFR 866.3330 | 5 | 0 |
| GNW | Antisera, Cf, Influenza Virus A, B, C | Class I | 21 CFR 866.3330 | 16 | 2 |
| GNX | Antigens, Cf (Including Cf Control), Influenza Virus A, B, C | Class I | 21 CFR 866.3330 | 18 | 10 |
| GNY | Antisera, Fluorescent, Adenovirus 1-33 | Class I | 21 CFR 866.3020 | 4 | 0 |
| GNZ | Antisera, Neutralization, Adenovirus 1-33 | Class I | 21 CFR 866.3020 | 0 | 0 |
| GOA | Antisera, Cf, Adenovirus 1-33 | Class I | 21 CFR 866.3020 | 1 | 0 |
| GOB | Antigens, Ha (Including Ha Control), Adenovirus 1-33 | Class I | 21 CFR 866.3020 | 1 | 0 |
| GOC | Antisera, Hai, Adenovirus 1-33 | Class I | 21 CFR 866.3020 | 0 | 0 |
| GOD | Antigens, Cf (Including Cf Control), Adenovirus 1-33 | Class I | 21 CFR 866.3020 | 11 | 1 |
| GOE | Antisera, Fluorescent, Poliovirus 1-3 | Class I | 21 CFR 866.3405 | 7 | 0 |
| GOF | Antisera, Neutralization, Poliovirus 1-3 | Class I | 21 CFR 866.3405 | 0 | 0 |
| GOG | Antisera, Cf, Poliovirus 1-3 | Class I | 21 CFR 866.3405 | 3 | 0 |
| GOH | Antigens, Cf (Including Cf Control), Poliovirus 1-3 | Class I | 21 CFR 866.3405 | 0 | 0 |
| GOI | Antiserum, Fluorescent, Rabies Virus | Class II | 21 CFR 866.3460 | 2 | 0 |
| GOJ | Antisera, Neutralization, Rubella | Class II | 21 CFR 866.3510 | 0 | 0 |
| GOK | Antisera, Hai (Including Hai Control), Rubella | Class II | 21 CFR 866.3510 | 11 | 0 |
| GOL | Antigen, Ha (Including Ha Control), Rubella | Class II | 21 CFR 866.3510 | 21 | 0 |
| GOM | Antisera, Cf, Rubella | Class II | 21 CFR 866.3510 | 2 | 0 |
| GON | Antigen, Cf (Including Cf Control), Rubella | Class II | 21 CFR 866.3510 | 5 | 0 |
| GOO | Antisera, Fluorescent, All Globulins, Salmonella Spp. | Class II | 21 CFR 866.3550 | 0 | 0 |
| GOP | Antisera, C. Acnes (553, 605) | Class I | 21 CFR 866.3140 | 0 | 0 |
| GOS | Antiserum, Fluorescent, C. Diphtheriae | Class I | 21 CFR 866.3140 | 0 | 0 |
| GOT | Antigen, B. Parapertussis | Class I | 21 CFR 866.3065 | 0 | 0 |
| GOW | Antisera, Agglutinating, B. Parapertussis | Class I | 21 CFR 866.3065 | 0 | 0 |
| GOX | Antigen, B. Pertussis | Class I | 21 CFR 866.3065 | 1 | 0 |
| GOY | Antisera, Agglutinating, B. Pertussis, All | Class I | 21 CFR 866.3065 | 1 | 1 |
| GOZ | Antisera, Fluorescent, B. Pertussis | Class I | 21 CFR 866.3065 | 0 | 0 |
| GPD | Antigen, Indirect Fluorescent Antibody Test, Echinococcus Granulosus | Class I | 21 CFR 866.3200 | 0 | 0 |
| GPE | Antisera, Positive Control, Echinococcus Spp. | Class I | 21 CFR 866.3200 | 0 | 0 |
| GPF | Antigen, Agglutinating, Echinococcus Spp. | Class I | 21 CFR 866.3200 | 1 | 0 |
| GPG | Antigen, Latex Agglutination, Trichinella Spiralis | Class I | 21 CFR 866.3850 | 2 | 0 |
| GPH | Antiserum, Bentonite Flocculation, Trichinella Spiralis | Class I | 21 CFR 866.3850 | 0 | 0 |
| GPI | Antigen, Bentonite Flocculation, Trichinella Spiralis | Class I | 21 CFR 866.3850 | 0 | 0 |
| GPJ | Antiserum, Fluorescent, Q Fever | Class I | 21 CFR 866.3500 | 2 | 0 |
| GPK | Antiserum, Rickettsial Pox | Class I | 21 CFR 866.3500 | 0 | 0 |
| GPM | Antiserum, Murine Typhus Fever | Class I | 21 CFR 866.3500 | 1 | 0 |
| GPN | Antiserum, Typhus Fever | Class I | 21 CFR 866.3500 | 1 | 1 |
| GPO | Antigen, Cf, Typhus Fever Group | Class I | 21 CFR 866.3500 | 1 | 0 |
| GPP | Antiserum, Rocky Mountain Spotted Fever | Class I | 21 CFR 866.3500 | 1 | 0 |
| GPQ | Antigen, Cf, Spotted Fever Group | Class I | 21 CFR 866.3500 | 0 | 0 |
| GPR | Antiserum, Cf, Q Fever | Class I | 21 CFR 866.3500 | 0 | 0 |
| GPS | Antigen, Cf, Q Fever | Class I | 21 CFR 866.3500 | 1 | 0 |
| GPT | Antiserum, Cf, Psittacosis (Chlamydia Group) | Class I | 21 CFR 866.3120 | 1 | 0 |
| GPW | Antigen, Cf, Psittacosis (Chlamydia Group) | Class I | 21 CFR 866.3120 | 4 | 0 |
| GPX | Antisera, Neutralizion, Reovirus 1-3 | Class I | 21 CFR 866.3470 | 0 | 0 |
| GPY | Antisera, Hai, Reovirus 1-3 | Class I | 21 CFR 866.3470 | 0 | 0 |
| GPZ | Antisera, Cf, Reovirus 1-3 | Class I | 21 CFR 866.3470 | 0 | 0 |
| GQA | Antigens, Ha (Including Ha Control), Reovirus 1-3 | Class I | 21 CFR 866.3470 | 0 | 0 |
| GQB | Antigens, Cf (Including Cf Control), Reovirus 1-3 | Class I | 21 CFR 866.3470 | 0 | 0 |
| GQC | Antisera, Cf, Equine Encephalitis Virus, Eee, Wee | Class I | 21 CFR 866.3240 | 2 | 0 |
| GQD | Antigens, Cf (Including Cf Control), Equine Encephalitis Virus, Eee, Wee | Class I | 21 CFR 866.3240 | 0 | 0 |
| GQE | Antisera, Neutralization, All Types, Rhinovirus | Class I | 21 CFR 866.3490 | 0 | 0 |
